Predicted protein targets (top 1)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | APLNR | P35414 | 1/20 | 0.47 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2001008 | 0.82 | APLNR (0.70) | APLNR | |
| SCHEMBL21064654 | 0.82 | KMT2A (0.34) | — | |
| SCHEMBL17300169 | 0.80 | KMT2A (0.34) | — | |
| SCHEMBL11711679 | 0.74 | APLNR (0.58) | APLNR | |
| SCHEMBL4758528 | 0.68 | — | — | |
| SCHEMBL3903198 | 0.68 | APLNR (1.00) | APLNR | |
| SCHEMBL289935 | 0.68 | — | — | |
| SCHEMBL6578208 | 0.68 | — | — | |
| SCHEMBL4751708 | 0.66 | APLNR (0.64) | APLNR | |
| SCHEMBL7910521 | 0.63 | APLNR (0.58) | APLNR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 19 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20170267803-A1 | CHAIN EXTENDERS | POLYNOVO BIOMATERIALS PTY LTD (AU) | 2017-09-21 | — | — | US | disclosed |
| US-20170267803-A1 | CHAIN EXTENDERS | POLYNOVO BIOMATERIALS PTY LTD (AU) | 2017-09-21 | — | — | US | disclosed |
| EP-3214071-A1 | ISOTHIOCYANATE COMPOSITION | Asahi Kasei Chemicals Corporation (JP) | 2017-09-06 | — | — | EP | disclosed |
| US-9695268-B2 | Chain extenders | POLYNOVO BIOMATERIALS PTY LIMITED (AU) | 2017-07-04 | — | — | US | disclosed |
| US-9695268-B2 | Chain extenders | POLYNOVO BIOMATERIALS PTY LIMITED (AU) | 2017-07-04 | — | — | US | disclosed |
| EP-1945690-B1 | CHAIN EXTENDERS | POLYNOVO BIOMATERIALS PTY LTD (AU) | 2016-07-27 | — | — | EP | disclosed |
| US-20160016901-A1 | ISOTHIOCYANATE PRODUCTION METHOD, COMPOSITION FOR TRANSPORTING AND STORING N-SUBSTITUTED O-SUBSTITUTED THIOCARBAMATE, AND ISOTHIOCYANATE COMPOSITION | ASAHI KASEI CHEMICALS CORPORATION (JP) | 2016-01-21 | — | — | US | disclosed |
| US-20160016901-A1 | ISOTHIOCYANATE PRODUCTION METHOD, COMPOSITION FOR TRANSPORTING AND STORING N-SUBSTITUTED O-SUBSTITUTED THIOCARBAMATE, AND ISOTHIOCYANATE COMPOSITION | ASAHI KASEI CHEMICALS CORPORATION (JP) | 2016-01-21 | — | — | US | disclosed |
| US-20150344613-A1 | POLYTHIOUREA COMPOSITIONS AND METHODS OF USE | EMPIRE TECHNOLOGY DEVELOPMENT LLC (US) | 2015-12-03 | — | — | US | disclosed |
| US-20150344613-A1 | POLYTHIOUREA COMPOSITIONS AND METHODS OF USE | EMPIRE TECHNOLOGY DEVELOPMENT LLC (US) | 2015-12-03 | — | — | US | disclosed |
| US-20150105530-A1 | CHAIN EXTENDERS | POLYNOVO BIOMATERIALS PTY LTD (AU) | 2015-04-16 | — | — | US | disclosed |
| US-20150105530-A1 | CHAIN EXTENDERS | POLYNOVO BIOMATERIALS PTY LTD (AU) | 2015-04-16 | — | — | US | disclosed |
| US-8962786-B2 | Chain extenders | POLYNOVO BIOMATERIALS PTY LTD (AU) | 2015-02-24 | — | — | US | disclosed |
| US-8962786-B2 | Chain extenders | POLYNOVO BIOMATERIALS PTY LTD (AU) | 2015-02-24 | — | — | US | disclosed |
| WO-2014136690-A1 | ISOTHIOCYANATE PRODUCTION METHOD, COMPOSITION FOR TRANSPORTING AND STORING N-SUBSTITUTED O-SUBSTITUTED THIOCARBAMATE, AND ISOTHIOCYANATE COMPOSITION | 旭化成ケミカルズ株式会社 (JP) | 2014-09-12 | — | — | WO | disclosed |
| US-20110287102-A1 | CHAIN EXTENDERS | POLYNOVO BIOMATERIALS PTY LIMITED (AU) | 2011-11-24 | — | — | US | disclosed |
| US-7964696-B2 | Chain extenders | POLYNOVO BIOMATERIALS PTY LIMITED (AU) | 2011-06-21 | — | — | US | disclosed |
| US-20090175921-A1 | Chain Extenders | POLYNOVO BIOMATERIALS PTY LIMITED | 2009-07-09 | — | — | US | disclosed |
| WO-2007033418-A1 | CHAIN EXTENDERS | POLYNOVO BIOMATERIALS PTY LIMITED (AU) | 2007-03-29 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20170267803-A1 | CHAIN EXTENDERS | UMPS, PUF60, SMCHD1 | APLNR 2409/4885 |
| US-20110287102-A1 | CHAIN EXTENDERS | UMPS, PUF60, SMCHD1 | APLNR 2409/4885 |
| US-20090175921-A1 | Chain Extenders | UMPS, PUF60, SMC1A | APLNR 2350/4885 |
| US-20160016901-A1 | ISOTHIOCYANATE PRODUCTION METHOD, COMPOSITION FOR TRANSPORTING AND STORING N-SUBSTITUTED O-SUBSTITUTED THIOCARBAMATE, AND ISOTHIOCYANATE COMPOSITION | TST, SLCO4C1, SLCO2B1 | APLNR 4157/4885 |
| US-20150344613-A1 | POLYTHIOUREA COMPOSITIONS AND METHODS OF USE | PNMT, SRM, PUF60 | APLNR 1356/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.